| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | IDEXX LABORATORIES CMN | Jun 30, 2026 | |
| Buy | IDEXX LABORATORIES INC. CMN | Feb 17, 2026 | |
| Sell | IDEXX Laboratories, Inc. | Jan 13, 2026 | |
| Sell | IDEXX Laboratories, Inc. | Dec 2, 2025 | |
| Sell | IDEXX Laboratories, Inc. | Oct 29, 2025 | |
| Sell | IDEXX Laboratories, Inc. | Oct 16, 2025 | |
| Sell | IDEXX LABORATORIES CMN | Sep 5, 2025 | |
| Buy | IDEXX Laboratories, Inc. | Sep 4, 2025 | |
| Sell | IDEXX Laboratories, Inc. | Aug 7, 2025 | |
| Sell | IDEXX LABORATORIES CMN | Aug 4, 2025 |
This page tracks congressional stock trading activity in IDEXX Laboratories, Inc. (IDXX) in the Healthcare sector. Disclosed Capitol has indexed 97 disclosed congressional trades involving IDXX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 97 disclosed congressional trades in IDEXX Laboratories, Inc. (IDXX) — 43:35 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Feb 17, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| Jan 13, 2026 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Dec 2, 2025 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Oct 29, 2025 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Oct 16, 2025 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Sep 5, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Sep 4, 2025 | Byron Donalds | R | Buy | $1,001 - $15,000 |
| Aug 7, 2025 | April McClain Delaney | D | Sale | $1,001 - $15,000 |
| Aug 4, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
Across the 97 disclosed congressional trades in IDEXX Laboratories, Inc. (IDXX), members of Congress have reported 43 buys and 35 sells. The average 30-day alpha vs. the S&P 500 is 1.05%.
As of December 2025, IDEXX Laboratories, Inc. has 24 federal contract award records on file from USAspending.gov — most recently $92K from the Department of Defense on 2025-12-17.
| Award date | Agency | Amount |
|---|---|---|
| 2025-12-17 | Department of Defense · Department of the Army | $92K |
| 2025-09-23 | Department of Agriculture · Agricultural Research Service | $111K |
| 2025-09-03 | Department of Defense · Department of the Army | $57K |
| 2025-02-03 | Department of Defense · Department of the Army | $87K |
| 2024-09-12 | Department of Defense · Department of the Army | $139K |
| 2024-09-05 | Department of Defense · Department of the Navy | $95K |
| 2024-02-05 | Department of Defense · Department of the Army | $82K |
| 2023-10-19 | Department of Defense · Department of the Navy | $88K |
| 2023-02-06 | Department of Defense · Department of the Army | $78K |
| 2022-11-04 | Department of Agriculture · Animal and Plant Health Inspection Service | $128K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, IDEXX Laboratories, Inc. reported revenue of $4.30B and net income of $1.06B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $2.36B, net income $616.9M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.